BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 170501)

  • 1. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
    Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
    J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC; Guccione MA; Packham MA; Mustard JF
    Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of functional compartments of cyclic AMP in rat platelets by the use of phosphodiesterase inhibitors.
    Ashida S; Sakuma K
    Adv Second Messenger Phosphoprotein Res; 1992; 25():229-39. PubMed ID: 1313259
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
    Ardelt W
    Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human platelet aggregation and cAMP system--cAMP level, adenyl cyclase, phosphodiesterase.
    Wang TY; Hussey CV; Sasse EA; Fobian JE
    Ann Clin Lab Sci; 1978; 8(5):403-12. PubMed ID: 213009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
    Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
    Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
    [No Abstract]   [Full Text] [Related]  

  • 10. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.
    Matsuoka I; Suzuki T
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate.
    Beretz A; Briançon-Scheid F; Stierlé A; Corre G; Anton R; Cazenave JP
    Biochem Pharmacol; 1986 Jan; 35(2):257-62. PubMed ID: 3002388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostaglandins and drotaverine on ADP-induced platelet aggregation.
    Losonczy H; Nagy I; Gregus Z
    Acta Med Acad Sci Hung; 1974; 31(3-4):157-63. PubMed ID: 4469713
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the role of cyclic 3',5'-adenosine monophosphate in platelet functions with special reference to aggregation and serotonin release of human blood platelets.
    Ryo R
    Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):85-96. PubMed ID: 183445
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of two distinct adenosine diphosphate receptors in human platelets.
    Colman RW; Figures WR; Colman RF; Morinelli TA; Niewiarowski S; Mills DC
    Trans Assoc Am Physicians; 1980; 93():305-16. PubMed ID: 6264660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP in human blood platelets: relation to platelet prostaglandin synthesis induced by centrifugation or surface contact.
    Salzman EW; Lindon JN; Rodvien R
    J Cyclic Nucleotide Res; 1976; 2(1):25-37. PubMed ID: 178701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fibroblast cyclic AMP escape and cyclic nucleotide phosphodiesterase activities by xanthines.
    Nemecek GM; Wells JN; Butcher RW
    Mol Pharmacol; 1980 Jul; 18(1):57-64. PubMed ID: 6251359
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
    Zahavi M; Zahavi J; Kakkar VV
    Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet cyclic 3',5'-adenosine-monophosphate phosphodiesterases by pentifylline.
    Stefanovich V
    Arzneimittelforschung; 1975 May; 25(5):740-1. PubMed ID: 170944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effect of a thymic epithelial culture supernate or thymosin fraction 5 on rabbit platelet aggregation and intracellular cyclic AMP levels.
    Hashimoto S; Itoh Y; Kawaguchi A; Mizuno Y; Muraoka M; Tsuchiya M
    J Cell Physiol; 1987 Dec; 133(3):499-506. PubMed ID: 2826498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.